Pleased to announce that I have moved to Nanjing Medical University, China and started a research group on #infectiousdiseases#Epidemiology and #modelling. Check out our group webpage at: https://t.co/7y1wxCzmwq
Pleased to re-attend RSVVW after missing quite a few RSV conferences for various reasons. Seeing lots of old friends and having met new colleagues in the community. #RSVVW26@ReSViNET
The four subtypes of parainfluenza have their distinct temporal patterns of circulation, particularly subtype 3, important for vaccine development and immunisation strategy.
Our new @LancetGH study reveals regional and type-specific variations in the global seasonality of human parainfluenza viruses and the climate drivers. Read more here: https://t.co/59vCSOAMwR
A great thread - check out our recently published work in Nat Commun suggesting that virus traits (rather than locations) explained the set order of resurgence of different respiratory viruses. Full text - https://t.co/hNc0U28W0M
▶️ What is driving the STRONG RESURGENCE of the FLU?
▶️ When can we EXPECT to RETURN to NORMAL patterns of respiratory virus circulation?
A recent key study in Nature sheds light on these two important questions.
https://t.co/DLdi1Ad0jM
It is not just meteorological factors - our recently published analysis in @BMCMedicine showing socio-demographic factors were also associated with #RSV#VRS season onset.
🦠Local-level variations in #RSV season onset could be as much as 6 weeks, which could be influenced by meteorological, geographical, and socio-demographic factors, discover Sheng @you_li2@XinWang1991 et al. from #NanjingMedicalUniversity@EdinUniUsher
https://t.co/XMPzfeESJg
Pleased to share our recently published work in @LancetGH on #RSV seasonality, transmission zones, and implications for seasonal prevention strategy in China @XinWang1991 https://t.co/SinIIrqpSw
Our latest work on #RSV epi in Beijing. Two abnormal seasons during COVID: one in 20-21 season with year-round activity; one in 22-23 season with an out-of-season spring peak. Interestingly, for both seasons, increased RSV+ve seen only in children.
https://t.co/gFc7hrzNfG
Also check out the 4-min video summary of our study findings on #RSV#VRS disease burden and risk factors in preterm infants and young children. @RESCEUproject@TheLancet
Follow the link below 👇
https://t.co/IaLbdyGmGe
Excited to share that our estimates on the global disease burden and risk factors for ALRI caused by RSV in preterm infants and young children are online in the Lancet @RESCEUproject
Another important work from collaborative efforts 👉
https://t.co/dPZ5mNQjhC
Given the changes in RSV epi after the onset of COVID, important to establish (or re-establish) RSV surveillance to monitor these changes, particularly in LMICs. (4/4)
Among RSV hospitalised children, a significantly higher % of 12–24m observed during COVID than in 2019, ORs ranging from 1.30 (1.07–1.59) to 2.05 (1.66–2.54).
No consistent changes in severity observed. (3/4)
Important paper with strong messages:
1. Higher #RSV & #flu hospitalisation rates in the Scottish population of higher deprived levels
2. For #RSV, the disparities by deprivation levels most pronounced in <5y children
3. For #flu, the disparities more apparent in those >1 year.
Our estimates of RSV hospital admissions across the Scottish Index of Multiple Deprivation levels @PROMISE_IMI@RESCEUproject have been published in JID👇
Age spectrum of RSV-associated hospitalisation and mortality burden based on statistical modelling methods: a systematic analysis
Nice to have the Figure summarising the RSV hospitalisation burden by age group
@you_li2@ProfHarishNair
https://t.co/HctzNb02yF
Our latest research on the full age spectrum of #RSV hospitalisation and mortality burden has been published in @BMCMedicine. We also compared the proportion of RSV disease burden captured by different case definitions. Full-text 👉 https://t.co/qjkD9UWUog
Check out our latest publication 👉Impact of subgroup distribution on seasonality of human respiratory syncytial virus: A global systematic analysis https://t.co/qnYLPMu9sK
@PROMISE_IMI#RSV
🎉We're excited to finally kick off @PROMISE_IMI General Assembly Meeting #4 in Utrecht🇳🇱 !
2⃣ days of insightful meetings to prepare for the project's final stretch of the race.
From #RSV Epidemiology & #COVID19 impact to patient engagement activities, there's much to do!💪
Pleased to have given a talk yesterday at the #ECCMID#ECCMID23 @ECCMID on global #RSV disease burden in adults in HICs. Really happy to be able to meet with colleagues in person (finally!!) after the pandemic.